title: The conflict of safety versus access to new therapies: the FDA, clinical trial design, and neuromodulation.
authors.forename: Robert M
authors.initials: RM
authors.lastname: Levy
mesh_terms: D002986:Clinical Trials as Topic; D046690:Deep Brain Stimulation / Q000295:instrumentation; D018795:Device Approval; D004567:Electrodes, Implanted; D006801:Humans; D018377:Neurotransmitter Agents / Q000627:therapeutic use*; D012107:Research Design; D012449:Safety; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D018377:Neurotransmitter Agents